Cargando…
Clinicopathological features of PD-L1 protein expression, EBV positivity, and MSI status in patients with advanced gastric and esophagogastric junction adenocarcinoma in Japan
This real-world study examined the prevalence of programmed death ligand-1 (PD-L1) expression and assessed the frequency of microsatellite instability-high (MSI-H) status and Epstein-Barr virus (EBV) positivity in Japanese patients with advanced gastric and gastroesophageal junction (GEJ) adenocarci...
Autores principales: | Yoshida, Tsutomu, Ogura, Go, Tanabe, Mikiko, Hayashi, Takuo, Ohbayashi, Chiho, Azuma, Mizutomo, Kunisaki, Chikara, Akazawa, Yoichi, Ozawa, Soji, Matsumoto, Sohei, Suzuki, Takayoshi, Mitoro, Akira, Fukunaga, Tetsu, Shimizu, Akiko, Fujimoto, Go, Yao, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890430/ https://www.ncbi.nlm.nih.gov/pubmed/35220884 http://dx.doi.org/10.1080/15384047.2022.2038002 |
Ejemplares similares
-
EBV and MSI Status in Gastric Cancer: Does It Matter?
por: do Nascimento, Catarina Neto, et al.
Publicado: (2022) -
Current surgical treatment of esophagogastric junction adenocarcinoma
por: Zhang, Shun, et al.
Publicado: (2019) -
MSI and EBV Positive Gastric Cancer’s Subgroups and Their Link with Novel Immunotherapy
por: Rodriquenz, Maria Grazia, et al.
Publicado: (2020) -
Mixed adenoneuroendocrine carcinoma of the esophagogastric junction: a case report
por: Yamamoto, Miho, et al.
Publicado: (2018) -
Agenesis of the Left Hepatic Lobe Accompanied by Esophagogastric Cancer: A Case Report and Literature Review
por: Yoshimoto, Yutaro, et al.
Publicado: (2022)